ID | 115979 |
タイトル別表記 | Remedy for improving ICC prognosis
|
著者 |
Tsuji, Tatsuya
Hasuda Clinic
Miyake, Hidenori
Tokushima Municipal Hospital
Kamo, Hitomi
Taoka Hospital
Sumise, Yuko
Taoka Hospital
Takai, Shigeharu
Taoka Hospital
Yoshioka, Kazuo
Taoka Hospital
|
キーワード | intrahepatic cholangiocarcinoma (ICC)
hepatocellular carcinoma (HCC)
hepatitis virus
nibolumab
lenvatinib
|
資料タイプ |
学術雑誌論文
|
抄録 | The prognosis of patients with intrahepatic cholangiocarcinoma (ICC) is still poor, and the 5-year survival rate in patients undergoing radical surgery (R0) is less than one-third. Since the prognosis depends mainly on tumor factors, so early diagnosis is necessary. To extend the survival time of these patients with a poor prognosis, cases of long-term survival were examined based on the results of our experiences and the literature. It was found that the hepatitis virus was highly involved in the carcinogenesis of ICC, and patients who were infected with hepatitis virus had rather good survival.
|
掲載誌名 |
The Journal of Medical Investigation
|
ISSN | 13496867
13431420
|
cat書誌ID | AA11166929
|
出版者 | Tokushima University Faculty of Medicine
|
巻 | 68
|
号 | 1-2
|
開始ページ | 15
|
終了ページ | 21
|
並び順 | 15
|
発行日 | 2021-02
|
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
医学系
|